Laurus Labs Ltd approves ₹32.50 crore cash investment for 52% of SI & C Resins at ₹30 crore pre-money valuation
- SI&C will become a subsidiary upon closing; Laurus may invest up to a further ₹30 crore as funding is required.
- The deal adds polymer- and silica-based resin development and manufacturing to Laurus’s peptide business.
- Completion is expected in FY27, subject to customary conditions and transfer of the business; the partnership firm reported FY26 turnover of ₹4.05 crore, versus ₹3.55 crore in FY25.